S-Bank Fund Management’s AbbVie ABBV Stock Holding History

S-Bank Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72M	Buy	10,822 +2,866	+36%	+$617K	0.37%	60
2026 Q1	$1.73M	Sell	7,956 -296	-4%	-$65.7K	0.26%	76
2025 Q4	$1.89M	Sell	8,252 -4,448	-35%	-$1.01M	0.24%	73
2025 Q3	$2.94M	Sell	12,700 -166	-1%	-$33.8K	0.39%	62
2025 Q2	$2.39M	Sell	12,866 -644	-5%	-$120K	0.35%	72
2025 Q1	$2.83M	Buy	+13,510	New	+$2.63M	0.53%	58

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

S-Bank Fund Management's ABBV Position: Q2 2026 in Review

S-Bank Fund Management increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $617K and bringing the position to 10,822 shares worth $2.72M. The position accounts for 0.37% of the portfolio, ranked #60.

S-Bank Fund Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.94M in Q3 2025. 2,511 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

S-Bank Fund Management held 10,822 shares of AbbVie worth $2.72M as of Q2 2026.
S-Bank Fund Management bought 2,866 AbbVie shares in Q2 2026, an estimated $617K.
AbbVie made up 0.37% of S-Bank Fund Management's portfolio in Q2 2026, its #60 holding.
S-Bank Fund Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
S-Bank Fund Management's AbbVie position peaked at $2.94M in Q3 2025.
2,511 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.